Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

907

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2009

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Abciximab

Abciximab bolus 0,25mg/kg, 10-60 minutes before PCI. Infusion 0,125ug/kg/min for 12 hours after PCI.

DEVICE

bare metal stent prokinetic, chrono, skylor or bluemedical

bare metal stent in culprit artery in acute myocardial infarction

DEVICE

drug eluting stent (sirolimus eluting) - CYPHER stent

stent implantation in culprit artery in acute myocardial infarction

Trial Locations (1)

Unknown

Catharina ziekenhuis, Eindhoven

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Compusense Oegstgeest ( electronic randomization and CRF)

UNKNOWN

collaborator

CATHREINE ( data monitoring)

UNKNOWN

lead

Catharina Ziekenhuis Eindhoven

OTHER

NCT00986050 - Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter